The most common cholesterol-lowering drugs may improve hospitalised Covid-19 patients’ chances of survival and reduce their risks of progressing to more severe disease, a new study suggests.
An analysis of more than 10,000 people admitted to more than 140 hospitals across the United States found that a class of medications called statins, together with blood pressure drugs, reduced in-hospital Covid-19 death by 40% among those who took them before being admitted.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!